Insulin glargine and incidence of cancer--an ongoing debate.
作者信息
Hermanns Norbert, Kulzer Bernd
出版信息
J Diabetes Sci Technol. 2010 Mar 1;4(2):497-8. doi: 10.1177/193229681000400235.
Abstract
摘要
相似文献
1
Insulin glargine and incidence of cancer--an ongoing debate.
J Diabetes Sci Technol. 2010 Mar 1;4(2):497-8. doi: 10.1177/193229681000400235.
2
Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues.
Diabetologia. 2010 Jan;53(1):204-5. doi: 10.1007/s00125-009-1572-8. Epub 2009 Oct 27.
3
Insulin glargine controversy: a tribute to the editorial team at Diabetologia.
Diabetes. 2009 Nov;58(11):2427-8. doi: 10.2337/db09-9030.
4
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study.
Diabetologia. 2009 Sep;52(9):1732-44. doi: 10.1007/s00125-009-1418-4. Epub 2009 Jun 30.
5
Insulin resistance and increased risk for malignant neoplasms: confounding of the data on insulin glargine.
Diabetologia. 2010 Jan;53(1):206-8. doi: 10.1007/s00125-009-1535-0. Epub 2009 Sep 24.
6
[Increased risk of cancer using insulin and insulin analogues?].
MMW Fortschr Med. 2010 Sep 9;152(36):39-41. doi: 10.1007/BF03366975.
7
Editorial: glargine, a new long-acting insulin analog for diabetic cats.
J Vet Intern Med. 2006 Mar-Apr;20(2):219-20. doi: 10.1892/0891-6640(2006)20[219:eganli]2.0.co;2.
8
Risk of cancer in patients receiving insulin glargine.
Am J Health Syst Pharm. 2010 Dec 1;67(23):2025-31. doi: 10.2146/ajhp100109.
9
Insulin glargine and malignancy: an unwarranted alarm.
Lancet. 2009 Aug 15;374(9689):511-3. doi: 10.1016/S0140-6736(09)61307-6. Epub 2009 Jul 17.
10
Insulin glargine and cancer--an unsubstantiated allegation.
Diabetes Technol Ther. 2009 Aug;11(8):473-6. doi: 10.1089/dia.2009.1705.
本文引用的文献
1
Combined randomised controlled trial experience of malignancies in studies using insulin glargine.
Diabetologia. 2009 Dec;52(12):2499-506. doi: 10.1007/s00125-009-1530-5. Epub 2009 Sep 15.
2
Insulin glargine and cancer: another side to the story?
Lancet. 2009 Aug 15;374(9689):521. doi: 10.1016/S0140-6736(09)61477-X.
3
Insulin glargine and malignancy: an unwarranted alarm.
Lancet. 2009 Aug 15;374(9689):511-3. doi: 10.1016/S0140-6736(09)61307-6. Epub 2009 Jul 17.
4
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study.
Diabetologia. 2009 Sep;52(9):1971-3. doi: 10.1007/s00125-009-1452-2. Epub 2009 Jul 16.
5
Insulin glargine and cancer--an unsubstantiated allegation.
Diabetes Technol Ther. 2009 Aug;11(8):473-6. doi: 10.1089/dia.2009.1705.
6
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study.
Diabetologia. 2009 Sep;52(9):1732-44. doi: 10.1007/s00125-009-1418-4. Epub 2009 Jun 30.
Zotero 插件